Walleye Capital LLC Roivant Sciences Ltd. Transaction History
Walleye Capital LLC
- $38.9 Billion
- Q4 2024
A detailed history of Walleye Capital LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Walleye Capital LLC holds 42,300 shares of ROIV stock, worth $439,074. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,300
Previous 50,300
15.9%
Holding current value
$439,074
Previous $580,000
13.79%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$683 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$644 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$496 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$458 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$367 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.31B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...